Cosmo Bio Company,Limited Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	542	504	369	653	790	1,099
Depreciation & Amortization	188	167	136	148	141	166
Loss (Gain) From Sale of Assets	61	58	1	-	-	-
Loss (Gain) From Sale of Investments	-110	-69	-5	-	-	-
Other Operating Activities	-193	-57	-194	-186	-280	-384
Change in Accounts Receivable	42	-83	-140	-40	-73	75
Change in Inventory	-7	-48	-25	97	-267	-245
Change in Accounts Payable	83	144	73	50	-22	-12
Change in Other Net Operating Assets	13	-21	26	14	-5	-51
Operating Cash Flow	619	595	241	736	284	648
Operating Cash Flow Growth	-0.96%	146.89%	-67.25%	159.16%	-56.17%	-19.30%
Capital Expenditures	-311	-229	-216	-67	-55	-31
Sale (Purchase) of Intangibles	-33	-52	-60	-33	-49	-110
Investment in Securities	520	361	103	-700	-202	-
Other Investing Activities	-28	-37	-44	42	15	-4
Investing Cash Flow	148	43	-217	-758	-291	-145
Repurchase of Common Stock	-	69	-299	-	-	-194
Common Dividends Paid	-283	-348	-175	-197	-232	-223
Other Financing Activities	-5	-4	-5	-4	-4	-3
Financing Cash Flow	-219	-283	-479	-201	-236	-420
Foreign Exchange Rate Adjustments	25	-1	22	13	24	12
Miscellaneous Cash Flow Adjustments	1	-	-	-	1	-
Net Cash Flow	574	354	-433	-210	-218	95
Free Cash Flow	308	366	25	669	229	617
Free Cash Flow Growth	-28.37%	1364.00%	-96.26%	192.14%	-62.89%	-19.56%
Free Cash Flow Margin	2.73%	3.40%	0.25%	7.16%	2.40%	6.68%
Free Cash Flow Per Share	54.24	64.36	4.30	114.78	39.45	106.22
Levered Free Cash Flow	167.5	397.38	-356.63	481.63	147.63	290.25
Unlevered Free Cash Flow	167.5	397.38	-356.63	481.63	147.63	290.25
Cash Income Tax Paid	191	57	193	185	279	385
Change in Working Capital	131	-8	-66	121	-367	-233